Pursuits
Apotex, Google, Lofgren, Uhlig, USPTO: Intellectual Property
This article is for subscribers only.
Apotex Inc. asked a judge to rule that its plan to market a generic version of the blood-pressure medicine Benicar won’t infringe patent rights held by drugmaker Daiichi Sankyo Co. or its American unit.
In a petition filed yesterday in federal court in Chicago, closely held Apotex said a finding of non-infringement on one of two relevant patents will let it compete sooner with Mylan Inc., the maker of generic drugs that also intends to sell a version of the medication.
Have a confidential tip for our reporters? Get in Touch
Before it’s here, it’s on the Bloomberg Terminal
LEARN MORE
Up Next
Apotex, Google, Lofgren, Uhlig, USPTO: Intellectual Property